BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28671770)

  • 1. Clinical outcomes of patients with resectable pancreatic acinar cell carcinoma.
    Seo S; Yoo C; Kim KP; Ryoo BY; Chang HM; Hong SM; Lee JH; Song KB; Hwang DW; Kim KH; Hwang S; Kim SC
    J Dig Dis; 2017 Aug; 18(8):480-486. PubMed ID: 28671770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing Regimen.
    Yoo C; Kim BJ; Kim KP; Lee JL; Kim TW; Ryoo BY; Chang HM
    Cancer Res Treat; 2017 Jul; 49(3):759-765. PubMed ID: 27857025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acinar cell carcinoma: a report of 19 cases with a brief review of the literature.
    Wang Y; Wang S; Zhou X; Zhou H; Cui Y; Li Q; Zhang L
    World J Surg Oncol; 2016 Jun; 14(1):172. PubMed ID: 27352960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma.
    Wisnoski NC; Townsend CM; Nealon WH; Freeman JL; Riall TS
    Surgery; 2008 Aug; 144(2):141-8. PubMed ID: 18656619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.
    Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P
    Oncology; 2015; 89(1):37-46. PubMed ID: 25766660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive approach to acinar cell carcinoma of the pancreas: a single-institution experience and a literature review.
    Butturini G; Pisano M; Scarpa A; D'Onofrio M; Auriemma A; Bassi C
    Langenbecks Arch Surg; 2011 Mar; 396(3):363-9. PubMed ID: 20803029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acinar cell carcinoma of the pancreas: an institutional series of resected patients and review of the current literature.
    Seth AK; Argani P; Campbell KA; Cameron JL; Pawlik TM; Schulick RD; Choti MA; Wolfgang CL
    J Gastrointest Surg; 2008 Jun; 12(6):1061-7. PubMed ID: 17957440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.
    Lovecek M; Skalicky P; Chudacek J; Szkorupa M; Svebisova H; Lemstrova R; Ehrmann J; Melichar B; Yogeswara T; Klos D; Vrba R; Havlik R; Mohelnikova-Duchonova B
    World J Gastroenterol; 2017 Sep; 23(35):6420-6428. PubMed ID: 29085191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
    Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
    Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic study of 62 acinar cell carcinomas of the pancreas: insights into the morphology and immunophenotype and search for prognostic markers.
    La Rosa S; Adsay V; Albarello L; Asioli S; Casnedi S; Franzi F; Marando A; Notohara K; Sessa F; Vanoli A; Zhang L; Capella C
    Am J Surg Pathol; 2012 Dec; 36(12):1782-95. PubMed ID: 23026929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOLFIRINOX as first-line treatment for unresectable acinar cell carcinoma of the pancreas: a case report.
    Schempf U; Sipos B; König C; Malek NP; Bitzer M; Plentz RR
    Z Gastroenterol; 2014 Feb; 52(2):200-3. PubMed ID: 24526405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.
    Nordby T; Hugenschmidt H; Fagerland MW; Ikdahl T; Buanes T; Labori KJ
    Eur J Surg Oncol; 2013 Jun; 39(6):559-66. PubMed ID: 23498362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.
    Labori KJ; Katz MH; Tzeng CW; Bjørnbeth BA; Cvancarova M; Edwin B; Kure EH; Eide TJ; Dueland S; Buanes T; Gladhaug IP
    Acta Oncol; 2016; 55(3):265-77. PubMed ID: 26213211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically resectable acinar cell carcinoma of the pancreas: Is there a benefit to adjuvant systemic therapy?
    Patel DJ; Lutfi W; Sweigert P; Eguia E; Abood G; Knab L; Kuo PC; Baker MS
    Am J Surg; 2020 Mar; 219(3):522-526. PubMed ID: 31677782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic acinar cell carcinoma: a multi-institutional study.
    Matos JM; Schmidt CM; Turrini O; Agaram NP; Niedergethmann M; Saeger HD; Merchant N; Johnson CS; Lillemoe KD; Grützmann R
    J Gastrointest Surg; 2009 Aug; 13(8):1495-502. PubMed ID: 19495891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: the Impact of Post-operative Chemotherapy.
    Syed AR; Carleton NM; Horne Z; Dhawan A; Bedi G; Kochhar G; Morrissey S; Williams H; Atkinson D; Schiffman S; Monga D; Lupetin A; Kirichenko A; Mitre M; Dhawan M; Kulkarni A; Thakkar S
    J Gastrointest Cancer; 2020 Sep; 51(3):836-843. PubMed ID: 31605289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation and outcome of mixed neuroendocrine non-neuroendocrine neoplasms of the pancreas.
    Nießen A; Schimmack S; Weber TF; Mayer P; Bergmann F; Hinz U; Büchler MW; Strobel O
    Pancreatology; 2021 Jan; 21(1):224-235. PubMed ID: 33309225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Span-1 and CA19-9 as Predictors of Early Recurrence and Lymph Node Metastasis for Patients with Invasive Pancreatic Cancer after Pancreatectomy.
    Shimizu T; Asakuma M; Tomioka A; Inoue Y; Hirokawa F; Hayashi M; Uchiyama K
    Am Surg; 2018 Jan; 84(1):109-113. PubMed ID: 29428036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curative resection of a primarily unresectable acinar cell carcinoma of the pancreas after chemotherapy.
    Distler M; Rückert F; Dittert DD; Stroszczynski C; Dobrowolski F; Kersting S; Grützmann R
    World J Surg Oncol; 2009 Feb; 7():22. PubMed ID: 19239719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Chronic" metastatic pancreatic acinar cell carcinoma.
    Cananzi FC; Jayanth A; Lorenzi B; Belgaumkar A; Mochlinski K; Sharma A; Mudan S; Cunningham D
    Pancreatology; 2013; 13(5):549-52. PubMed ID: 24075523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.